The Science and Medicine of Parkinson’s Disease

WebCAST

Webcast CME Disclosure

Please read this notice and click the acknowledgement
at the bottom of the page to continue.

Release Date:

June 1, 2009

Expiration Date:

June 1, 2011

Intended Audience:

The educational activity is designed for all physicians, nurses, NPs, academicians, pharmacists, researchers, investigators, and program directors from the fields of neurology, movement disorders, geriatrics, geropsychiatry, internal medicine, primary care, and related disciplines who care for patients with Parkinson’s Disease

Registration:

Enrollment for this WebCAST is complimentary, and clinicians are invited to participate in this CME-certified WebCAST and/or share this invitation with other colleagues, departmental staff members, and healthcare professionals.

Grantor Support:

Supported by an independent educational grant from Teva Neuroscience, Inc.
 

Accreditation Statement:

This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship of The University of Massachusetts Medical School, Office of CME and CMEducation Resources, LLC. The University of Massachusetts Medical School is accredited by the ACCME to provide continuing medical education for physicians.

Credit Designation Statement:

The University of Massachusetts Medical School designates this educational activity for a maximum of 3.0 AMA PRA Category 1 Credit(s). Physicians should only claim credit commensurate with the extent of their participation in the activity.

Policy on Faculty & Provider Disclosure:

It is the policy of the University of Massachusetts Medical School to ensure fair balance, independence, objectivity and scientific rigor in all activities. All faculty participating in CME activities sponsored by the University of Massachusetts Medical School are required to present evidence-based data, identify and reference off-label product use and disclose all relevant financial relationships with those supporting the activity or others whose products or services are discussed. Faculty disclosure will be provided in the activity materials.

Program Faculty and Disclosures:

Robert A. Hauser, MD, MBA – Program Chairman
Professor of Neurology, Molecular Pharmacology and Physiology
Director Clinical Signature Interdisciplinary Program in Neuroscience
Director, Clinical Center for Movement Disorders
University of South Florida
College of Medicine
Tampa, FL

Consultant/Advisory/Speaker’s Bureau: Allergan Neuroscience, AlphMedica, ApotheCom, Axis Health Care, Bayer-Shering, Boehringer Ingelheim, CNS Schering Plough, Centopharm, Embryon, Eisai, Genzyme ,GlaxoSmithKline, Impax, Ipsen Pharmaceuticals (formerly Vernalis), Kyowa Pharmaceutical, Merck, Novartis, Ortho McNeil, Pfizer, Prestwick, Quintiles, Santhera, Schwarz Pharma, Schering Plough, Solvay, Teva Neuroscience, Valeant, Vernalis (now Ipsen Pharmaceuticals)

Mark F. Lew, MD, FAAN
Professor of Neurology
Director Division of Movement Disorders
Vice Chair, Department of Neurology
Keck/USC School of Medicine
Los Angeles, CA

Grant/Research: Teva, BI, GSK, Kyowa, Solstice, Novartis, Schwarz Pharma/UCB, Ipsen, NIH, Eisai, Mentor, Solvay, Schering Plough
Consultant: Teva, BI, Solstice, Novartis, valeant, Ipsen, Schering Plough, GSK, Solvay
Speaker’s Bureau: Teva, GSK, Boerhinger-Ingelheim, Allergan, Solstice

Richard B. Dewey, Jr., MD, FAAN
Professor of Neurology
Director, Clinical Center for Movement Disorders
UT Southwestern Medical School
Dallas, TX

Grant/Research: NIH
Consultant: Teva Neuroscience Speaker’s Bureau: Teva Neuroscience, GSK, Boerhinger- Ingelheim, Novartis Pharmaceuticals

Educational Objectives:

Participants in this CME-certified WebCAST will:

• Learn to risk stratify, screen for, and evaluate patients with suspected or possible risk for Parkinson’s Disease (PD), and identify optimal therapeutic approaches.

• Learn to undertake a systematic evaluation of patients at risk for PD, including neurological exam, radiologi cal examination, and appropriate laboratory markers.

• Learn evidence-based approaches to reducing progression of PD, and sequencing pharmacological approaches in patients requiring monotherapy combi nation therapy for PD.

• Learn how to select safe and effective pharmaco therapy for treatment of PD.

• Learn how issues related to dosing, dosing sched ules, compliance, persistence, and adherence may impact patient preferences and outcomes in patients with PD.

Disclaimer:

Copyright © 2009 by Pharmatecture, LLC and CMEducation Resources, LLC All rights reserved.

Reproduction, distribution, or translation without express written permission is strictly prohibited.

Content on this webcast reflects the opinions, output, and analyses of experts, investigators, educators, and clinicians whose activities for, while independent, are commercially supported by the sponsor noted at the start of each activity.
Content on this webcast is not meant to be, nor substitute for national guidelines or recommendations generated by professional, academic societies, colleges, or associations.

Content on this webcast is intended for educational value only. Its contents, analyses, and any recommendation made herein are intended to make scientific information and opinion available to health professionals, to stimulate thought, and further investigation. This webcast is not designed nor is any aspect of the contents here intended to provide advice regarding medical diagnosis or treatment for any individual case. Any decisions regarding diagnosis and/or management of any individual patient or group of patients should be made on individual basis after having consulted appropriate sources, whether they be appropriate consultants and/or guidelines and recommendations issued by national organizations, professional societies, governmental health organizations, or similar bodies. This webcast is not intended for use by the layman.

Opinions expressed herein are not necessarily those of Pharmatecture, LLC, CMEducation Resources, LLC, program supporters or accreditors, but reflect the opinions and analyses of the experts who have authored the material. Mention of products or services does not constitute endorsement. Clinical, legal, financial, and other comments are offered for general guidance only; and professional counsel should be sought for all specific situations.

Copyright © 2009 All rights reserved